title: Femoral pseudoaneurysms post-cardiac catheterization surgically treated: evolution and prognosis.
abstract: OBJECTIVE
  To analyze the postoperative complications of patients who have undergone surgical repair of femoral pseudoaneurysm after cardiac catheterization.
  
  
  METHODS
  Prospective study.
  
  
  METHODS
  Cardiovascular risk factors, related to surgery and cardiac catheterization were collected prospectively in 79 patients from 2003 to 2006 in Valladolid University Hospital. The indications of surgery included necrosis of adjacent soft tissue, rapid growth, infection, bleeding, hemodynamic instability or failure of the percutaneous treatment (US-guided compression and US-guided percutaneous thrombin injection).
  
  
  METHODS
  Patient and management related predictors for 30-day outcome were analyzed.
  
  
  RESULTS
  Fifty-six patients (56/79, 71%) experienced some type of postoperative complication, the most frequent being the need for a transfusion. Infection (15/79, 19%) and dehiscence of the surgical wound (10/79, 12.7%) were the other two most common complications. The mortality related to the intervention was 3.8% (3/79). The mean hospital stay was 32.5 days (+/-28.4 days). Significant risk factors in logistic regression model were gender (P=0.023, OR=9.66), 70 years old (P=0.049, OR=0.15) and the concurrent use of anticoagulation or antiplatelet therapy after the cardiac catheterization (P=0.005, OR=0.03).
  
  
  CONCLUSIONS
  Patients who undergo surgical treatment of femoral pseudoaneurysm post-cardiac catheterization experience a high postoperative morbidity and hospital stay. Factors such as female gender, age over 70 years and treatment with anticoagulants or antiplatelets increase the postoperative morbidity. A seasonal influence was appreciated, with a higher frequency during the summer period.
authors.affiliation: Division of Vascular Surgery, Valladolid University Hospital, Valladolid, Spain. esannorberto@hotmail.com
authors.forename: Enrique M
authors.initials: EM
authors.lastname: San Norberto García
authors.forename: José-Antonio
authors.initials: JA
authors.lastname: González-Fajardo
authors.forename: Vicente
authors.initials: V
authors.lastname: Gutiérrez
authors.forename: Santiago
authors.initials: S
authors.lastname: Carrera
authors.forename: Carlos
authors.initials: C
authors.lastname: Vaquero
mesh_terms: D000367:Age Factors; D000368:Aged; D000369:Aged, 80 and over; D017541:Aneurysm, False / Q000209:etiology / Q000601:surgery*; D000925:Anticoagulants / Q000009:adverse effects; D001803:Blood Transfusion; D006328:Cardiac Catheterization / Q000009:adverse effects*; D005260:Female; D005263:Femoral Artery / Q000601:surgery*; D006801:Humans; D007902:Length of Stay; D016015:Logistic Models; D008297:Male; D008875:Middle Aged; D016017:Odds Ratio; D010975:Platelet Aggregation Inhibitors / Q000009:adverse effects; D019106:Postoperative Hemorrhage / Q000209:etiology / Q000628:therapy; D011446:Prospective Studies; D018570:Risk Assessment; D012307:Risk Factors; D012621:Seasons; D012737:Sex Factors; D013529:Surgical Wound Dehiscence / Q000209:etiology; D013530:Surgical Wound Infection / Q000209:etiology; D013997:Time Factors; D016896:Treatment Outcome; D014656:Vascular Surgical Procedures / Q000009:adverse effects* / Q000401:mortality
chemical_list: D000925:Anticoagulants; D010975:Platelet Aggregation Inhibitors